Zhen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhen Zhang has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Huiqun Zhou
8 shared publications- Dong-An Wang
Department of Biomedical Engineering City University of Hong Kong Kowloon Hong Kong 999077 P. R. China
7 shared publications Bangheng Liu
4 shared publicationsYang Shuai
3 shared publicationsYurui Cheng
3 shared publicationsDong-An Wang
2 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Elsevier in SSRN Electronic Journal
A Bio-crosslinked Extracellular Matrix Mimicry Catechol Modified Hydrogel with Multifunctional Bioactivity for Solid Organ Tissue Repair
Effective repair of traumatic and surgical wounds in solid organs remains a significant clinical challenge, requiring biomaterials that can achieve rapid hemostasis, prevent infection, limit fibrotic encapsulation, and promote functional tissue repair. In this study, a biomimetic transglutaminase (TGase) crosslinked gelatin–citrate–catechol (GCC) hydrogel was designed to meet these multifaceted requirements. Sequential grafting of citric acid and catechol onto gelatin, confirmed by spectroscopic analyses, endowed the hydrogel with robust wet adhesion, porous microstructure, and improved physicochemical properties. GCC hydrogels exhibit good cellular compatibility and support cell proliferation and spreading. In vivo, GCC achieved superior hemostasis in liver and tail bleeding models, reducing blood loss and clotting time versus gelatin, while also showing enhanced bacteriostatic activity against S. aureus. In long-term tissue repair studies using partial hepatectomy and splenectomy models, GCC effectively attenuated early postoperative inflammation, as evidenced by reduced pro-inflammatory cytokine secretion and mitigated systemic immune stress, while concurrently promoting tissue integration, parenchymal regeneration, and shift from pathological inflammation toward a pro-regenerative, anti-fibrotic microenvironment. Transcriptomic analysis revealed that GCC resolved inflammation, preserved metabolism, activated remodelling pathways, and suppressed fibrotic signalling (TNF, NF-κB, TGF-β). Collectively, these findings establish GCC as a promising multifunctional scaffold for repairing vascularized solid organ wounds.
- 2 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Bio-crosslinked Extracellular Matrix Mimicry Catechol Modified Hydrogel with Multifunctional Bioactivity for Solid Organ Tissue Repair
Effective repair of traumatic and surgical wounds in solid organs remains a significant clinical challenge, requiring biomaterials that can achieve rapid hemostasis, prevent infection, limit fibrotic encapsulation, and promote functional tissue repair. In this study, a biomimetic transglutaminase (TGase) crosslinked gelatin–citrate–catechol (GCC) hydrogel was designed to meet these multifaceted requirements. Sequential grafting of citric acid and catechol onto gelatin, confirmed by spectroscopic analyses, endowed the hydrogel with robust wet adhesion, porous microstructure, and improved physicochemical properties. GCC hydrogels exhibit good cellular compatibility and support cell proliferation and spreading. In vivo, GCC achieved superior hemostasis in liver and tail bleeding models, reducing blood loss and clotting time versus gelatin, while also showing enhanced bacteriostatic activity against S. aureus. In long-term tissue repair studies using partial hepatectomy and splenectomy models, GCC effectively attenuated early postoperative inflammation, as evidenced by reduced pro-inflammatory cytokine secretion and mitigated systemic immune stress, while concurrently promoting tissue integration, parenchymal regeneration, and shift from pathological inflammation toward a pro-regenerative, anti-fibrotic microenvironment. Transcriptomic analysis revealed that GCC resolved inflammation, preserved metabolism, activated remodelling pathways, and suppressed fibrotic signalling (TNF, NF-κB, TGF-β). Collectively, these findings establish GCC as a promising multifunctional scaffold for repairing vascularized solid organ wounds.
- Open Access
- 30 September 2026
- Published by Elsevier in SSRN Electronic Journal
In vitro Modeling of Arthritis: From 2D Cultures to Engineered 3D Biomimetic Tissue Platforms
Arthritis is a highly prevalent and heterogeneous disease with multifactorial pathogenesis that remains incompletely understood, creating substantial challenges for mechanistic investigation and therapeutic development. Conventional cell-based assays and animal models exhibit inherent limitations in preclinical drug screening, largely due to insufficient tissue-level complexity and interspecies differences, respectively, which contribute to the high attrition rate in clinical translation. Recent advances in bioengineering and microphysiological technologies have enabled the development of in vitro models that more faithfully recapitulate joint architecture and function, providing improved platforms for mechanistic investigation and therapeutic evaluation. This review outlines the core components of in vitro arthritic model construction, including cell sources, matrix materials, and disease-inducing factors, and systematically categorizes existing platforms into planar systems and three-dimensional culture approaches. Representative studies are analyzed to highlight model design strategies, characterization methodologies, and scalability considerations. Current challenges and future perspectives are also discussed, with an emphasis on the promise of these emerging systems to deepen mechanistic understanding and accelerate the translation of clinically effective therapies.
- 30 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIn vitro Modeling of Arthritis: From 2D Cultures to Engineered 3D Biomimetic Tissue Platforms
Arthritis is a highly prevalent and heterogeneous disease with multifactorial pathogenesis that remains incompletely understood, creating substantial challenges for mechanistic investigation and therapeutic development. Conventional cell-based assays and animal models exhibit inherent limitations in preclinical drug screening, largely due to insufficient tissue-level complexity and interspecies differences, respectively, which contribute to the high attrition rate in clinical translation. Recent advances in bioengineering and microphysiological technologies have enabled the development of in vitro models that more faithfully recapitulate joint architecture and function, providing improved platforms for mechanistic investigation and therapeutic evaluation. This review outlines the core components of in vitro arthritic model construction, including cell sources, matrix materials, and disease-inducing factors, and systematically categorizes existing platforms into planar systems and three-dimensional culture approaches. Representative studies are analyzed to highlight model design strategies, characterization methodologies, and scalability considerations. Current challenges and future perspectives are also discussed, with an emphasis on the promise of these emerging systems to deepen mechanistic understanding and accelerate the translation of clinically effective therapies.
- Open Access
Mechanism study of an articular cartilage repair material and its forward‐looking test for space medicine
While a novel tissue‐engineered scaffold (dLhCG) has demonstrated promising regenerative capabilities in terrestrial studies, the mechanisms underlying dLhCG‐mediated tissue regeneration remain poorly understood. The unique physiological challenges posed by prolonged space exploration to human articular cartilage necessitate the development of innovative regenerative solutions for space medicine. To address this need, dLhCG scaffolds were exposed to a 6‐month space environment aboard the China Tiangong Space Station, positioned both inside and outside the spacecraft, while control scaffolds were maintained on the ground. Our findings revealed that the regeneration process following dLhCG implantation progressed through four stages, during which dLhCG facilitated osteochondral regeneration by temporally modulating interactions with chondrocytes and osteoblasts, activating specific signaling pathways at distinct postoperative stages. Notably, although cosmic radiation increased protein denaturation and reduced the Young's modulus of the scaffold at the nanoscale, dLhCG maintained its macrostructural stability, preserved immunohistochemical properties, and retained the capacity to repair critical‐sized osteochondral defects in rats. These results highlight the resilience of dLhCG to cosmic conditions and underscore its potential as a viable material for cartilage repair in space medicine.
Open AccessMechanism study of an articular cartilage repair material and its forward‐looking test for space medicine
While a novel tissue‐engineered scaffold (dLhCG) has demonstrated promising regenerative capabilities in terrestrial studies, the mechanisms underlying dLhCG‐mediated tissue regeneration remain poorly understood. The unique physiological challenges posed by prolonged space exploration to human articular cartilage necessitate the development of innovative regenerative solutions for space medicine. To address this need, dLhCG scaffolds were exposed to a 6‐month space environment aboard the China Tiangong Space Station, positioned both inside and outside the spacecraft, while control scaffolds were maintained on the ground. Our findings revealed that the regeneration process following dLhCG implantation progressed through four stages, during which dLhCG facilitated osteochondral regeneration by temporally modulating interactions with chondrocytes and osteoblasts, activating specific signaling pathways at distinct postoperative stages. Notably, although cosmic radiation increased protein denaturation and reduced the Young's modulus of the scaffold at the nanoscale, dLhCG maintained its macrostructural stability, preserved immunohistochemical properties, and retained the capacity to repair critical‐sized osteochondral defects in rats. These results highlight the resilience of dLhCG to cosmic conditions and underscore its potential as a viable material for cartilage repair in space medicine.
- Open Access
- 16 July 2026
- Published by Elsevier in SSRN Electronic Journal
Construction of Gouty Arthritis Organoids with 3D Bioprinted Human Synovium-Cartilage Systems for Drug Identification and Evaluation
Current research on human gouty arthritis (GA) lacks in vitro models that can faithfully replicate native synovium and cartilage pathophysiology. Here, this work describes human synovium-cartilage organoid culture systems composed of type II collagen-based scaffolds repopulated with human chondrocytes and 3D-bioprinted tri-lamellar hydrogels, wherein the top layer recapitulates the synovial sublining by incorporating human proinflammatory macrophages and human umbilical vein endothelial cells, whereas the synovial lining layer is collectively reconstituted by the middle layer laden with human synovial fibroblasts and the bottom layer harboring human protective barrier macrophages. Monosodium urate crystals (MSUs) are supplemented into the optimized 3D co-culture system to cooperatively initiate the inflammatory cascade. The system accurately reproduces GA-associated tissue damage, inflammation, and extracellular matrix degradation, and is responsive to anti-gout drugs including colchicine and quercetin. Transcriptomic profiling identifies inflammatory response and vascular development as pivotal regulators of pathological alterations underlying GA. Building on these mechanistic insights, proteomics analysis and validating experiments demonstrated that paeoniflorin (Pae), an anti-inflammatory and anti-angiogenic monoterpene glycoside, attenuates inflammation and neovascularization in the established GA model by inhibiting the expression of COX2 and VEGFR1. Furthermore, Pae is found to alleviate the disease progression in a mouse model of MSU-induced GA. This study provides a promising human synovium-cartilage in vitro platform for preclinical anti-gout drugs screening and identifies potential therapeutic candidates for GA treatment.
- 16 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessConstruction of Gouty Arthritis Organoids with 3D Bioprinted Human Synovium-Cartilage Systems for Drug Identification and Evaluation
Current research on human gouty arthritis (GA) lacks in vitro models that can faithfully replicate native synovium and cartilage pathophysiology. Here, this work describes human synovium-cartilage organoid culture systems composed of type II collagen-based scaffolds repopulated with human chondrocytes and 3D-bioprinted tri-lamellar hydrogels, wherein the top layer recapitulates the synovial sublining by incorporating human proinflammatory macrophages and human umbilical vein endothelial cells, whereas the synovial lining layer is collectively reconstituted by the middle layer laden with human synovial fibroblasts and the bottom layer harboring human protective barrier macrophages. Monosodium urate crystals (MSUs) are supplemented into the optimized 3D co-culture system to cooperatively initiate the inflammatory cascade. The system accurately reproduces GA-associated tissue damage, inflammation, and extracellular matrix degradation, and is responsive to anti-gout drugs including colchicine and quercetin. Transcriptomic profiling identifies inflammatory response and vascular development as pivotal regulators of pathological alterations underlying GA. Building on these mechanistic insights, proteomics analysis and validating experiments demonstrated that paeoniflorin (Pae), an anti-inflammatory and anti-angiogenic monoterpene glycoside, attenuates inflammation and neovascularization in the established GA model by inhibiting the expression of COX2 and VEGFR1. Furthermore, Pae is found to alleviate the disease progression in a mouse model of MSU-induced GA. This study provides a promising human synovium-cartilage in vitro platform for preclinical anti-gout drugs screening and identifies potential therapeutic candidates for GA treatment.
- Open Access
- 1 August 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 50, 364-381
In situ implantation of type II collagen-based double-layer scaffolds for Articular Osteochondral Regeneration comprising hyaline cartilage and vascularized subchondral bones
The articular osteochondral injury involves the repair of hyaline cartilage, subchondral bone plate, and cancellous bone. Due to the weak regeneration ability of chondrocytes and the complex structure of the bone-cartilage junction, there is currently no excellent repair method. The challenge of hyaline cartilage repair is to avoid fibrosis and hypertrophy, which has been solved to some extent after the advent of type II collagen scaffolds; the difficulty of the subchondral bone plate and cancellous bone repair lies in the repair of the complex transition structure of cartilage tidemark, calcified cartilage, subchondral bone plate, and cancellous bone. Inspired by developmental biology, the generation of this complex structure during development depends on endochondral ossification (ECO). ECO depends on some specific proteins, such as IHH, PTHrP, BMP, and WNT, and the receptors of these proteins. Studies have shown that polydopamine coating can promote the production of BMP and WNT proteins. We developed a type II collagen-based double-layer scaffold (Col II & Dopa-Col II) with type II collagen on the upper layer and polydopamine-coated type II collagen on the lower layer. Proteomics and RNA sequencing analysis have found that polydopamine coating can mobilize the proliferation and hypertrophy differentiation of chondrocytes, induce intra-chondral vascular nerve invasion, and promote ECO and bone remodeling by upregulating Parathyroid hormone signaling pathway, Hedgehog signaling pathway, VEGF signaling pathway, and Axon guidance. All the results indicate that Col II & Dopa-Col II can achieve hyaline cartilage and vascularized subchondral bone regeneration.
- 1 August 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 50, 364-381
Open AccessIn situ implantation of type II collagen-based double-layer scaffolds for Articular Osteochondral Regeneration comprising hyaline cartilage and vascularized subchondral bones
The articular osteochondral injury involves the repair of hyaline cartilage, subchondral bone plate, and cancellous bone. Due to the weak regeneration ability of chondrocytes and the complex structure of the bone-cartilage junction, there is currently no excellent repair method. The challenge of hyaline cartilage repair is to avoid fibrosis and hypertrophy, which has been solved to some extent after the advent of type II collagen scaffolds; the difficulty of the subchondral bone plate and cancellous bone repair lies in the repair of the complex transition structure of cartilage tidemark, calcified cartilage, subchondral bone plate, and cancellous bone. Inspired by developmental biology, the generation of this complex structure during development depends on endochondral ossification (ECO). ECO depends on some specific proteins, such as IHH, PTHrP, BMP, and WNT, and the receptors of these proteins. Studies have shown that polydopamine coating can promote the production of BMP and WNT proteins. We developed a type II collagen-based double-layer scaffold (Col II & Dopa-Col II) with type II collagen on the upper layer and polydopamine-coated type II collagen on the lower layer. Proteomics and RNA sequencing analysis have found that polydopamine coating can mobilize the proliferation and hypertrophy differentiation of chondrocytes, induce intra-chondral vascular nerve invasion, and promote ECO and bone remodeling by upregulating Parathyroid hormone signaling pathway, Hedgehog signaling pathway, VEGF signaling pathway, and Axon guidance. All the results indicate that Col II & Dopa-Col II can achieve hyaline cartilage and vascularized subchondral bone regeneration.
- 9 July 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (16) , 4045-4064
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
The innovative and efficacious application of nanotechnology for remodeling the glioblastoma (GBM) tumor microenvironment (TME) exhibits promising potential as a therapeutic avenue for GBM treatment.
- 9 July 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (16) , 4045-4064
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
The innovative and efficacious application of nanotechnology for remodeling the glioblastoma (GBM) tumor microenvironment (TME) exhibits promising potential as a therapeutic avenue for GBM treatment.
- Open Access
- 1 May 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 35, 416-428
Type II collagen scaffolds repair critical-sized osteochondral defects under induced conditions of osteoarthritis in rat knee joints via inhibiting TGF-β-Smad1/5/8 signaling pathway
The bidirectional relationship between osteochondral defects (OCD) and osteoarthritis (OA), with each condition exacerbating the other, makes OCD regeneration in the presence of OA challenging. Type II collagen (Col2) is important in OCD regeneration and the management of OA, but its potential applications in cartilage tissue engineering are significantly limited. This study investigated the regeneration capacity of Col2 scaffolds in critical-sized OCDs under surgically induced OA conditions and explored the underlying mechanisms that promoted OCD regeneration. Furthermore, the repair potential of Col2 scaffolds was validated in over critical-sized OCD models. After 90 days or 150 days since scaffold implantation, complete healing was observed histologically in critical-sized OCD, evidenced by the excellent integration with surrounding native tissues. The newly formed tissue biochemically resembled adjacent natural tissue and exhibited comparable biomechanical properties. The regenerated OA tissue demonstrated lower expression of genes associated with cartilage degradation than native OA tissue but comparable expression of genes related to osteochondral anabolism compared with normal tissue. Additionally, transcriptome and proteome analysis revealed the hindrance of TGF-β-Smad1/5/8 in regenerated OA tissue. In conclusion, the engrafting of Col2 scaffolds led to the successful regeneration of critical-sized OCDs under surgically induced OA conditions by inhibiting the TGF-β-Smad1/5/8 signaling pathway.
- 1 May 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 35, 416-428
Open AccessType II collagen scaffolds repair critical-sized osteochondral defects under induced conditions of osteoarthritis in rat knee joints via inhibiting TGF-β-Smad1/5/8 signaling pathway
The bidirectional relationship between osteochondral defects (OCD) and osteoarthritis (OA), with each condition exacerbating the other, makes OCD regeneration in the presence of OA challenging. Type II collagen (Col2) is important in OCD regeneration and the management of OA, but its potential applications in cartilage tissue engineering are significantly limited. This study investigated the regeneration capacity of Col2 scaffolds in critical-sized OCDs under surgically induced OA conditions and explored the underlying mechanisms that promoted OCD regeneration. Furthermore, the repair potential of Col2 scaffolds was validated in over critical-sized OCD models. After 90 days or 150 days since scaffold implantation, complete healing was observed histologically in critical-sized OCD, evidenced by the excellent integration with surrounding native tissues. The newly formed tissue biochemically resembled adjacent natural tissue and exhibited comparable biomechanical properties. The regenerated OA tissue demonstrated lower expression of genes associated with cartilage degradation than native OA tissue but comparable expression of genes related to osteochondral anabolism compared with normal tissue. Additionally, transcriptome and proteome analysis revealed the hindrance of TGF-β-Smad1/5/8 in regenerated OA tissue. In conclusion, the engrafting of Col2 scaffolds led to the successful regeneration of critical-sized OCDs under surgically induced OA conditions by inhibiting the TGF-β-Smad1/5/8 signaling pathway.
- Open Access
- 3 December 2023
- Published by Elsevier in Materials Today Bio
- Vol. 23, 100893
Development of artificial bone graft via in vitro endochondral ossification (ECO) strategy for bone repair
- 3 December 2023
- Published by Elsevier in Materials Today Bio
- Vol. 23, 100893
Open AccessDevelopment of artificial bone graft via in vitro endochondral ossification (ECO) strategy for bone repair
- 1 October 2023
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
- Vol. 29 (5) , 473-490
Cartilage Tissue Engineering in Practice: Preclinical Trials, Clinical Applications, and Prospects
Articular cartilage defects significantly compromise the quality of life in the global population. Although many strategies to repair articular cartilage, including microfracture, autologous osteochondral transplantation, and osteochondral allograft, the therapeutic effects remain suboptimal. In recent years, with the development of cartilage tissue engineering, scientists have continuously improved the formulations of therapeutic cells, biomaterial-based scaffolds, and biological factors, which have opened new avenues for better therapeutics of cartilage lesions. This review focuses on advances in cartilage tissue engineering, particularly in preclinical trials and clinical applications, prospects, and challenges.
- 1 October 2023
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
- Vol. 29 (5) , 473-490
Cartilage Tissue Engineering in Practice: Preclinical Trials, Clinical Applications, and Prospects
Articular cartilage defects significantly compromise the quality of life in the global population. Although many strategies to repair articular cartilage, including microfracture, autologous osteochondral transplantation, and osteochondral allograft, the therapeutic effects remain suboptimal. In recent years, with the development of cartilage tissue engineering, scientists have continuously improved the formulations of therapeutic cells, biomaterial-based scaffolds, and biological factors, which have opened new avenues for better therapeutics of cartilage lesions. This review focuses on advances in cartilage tissue engineering, particularly in preclinical trials and clinical applications, prospects, and challenges.
- Open Access
- 13 October 2020
- Published by Wiley in Health Expectations
- Vol. 23 (6) , 1614-1626
Seeking or contributing? Evidence of knowledge sharing behaviours in promoting patients’ perceived value of online health communities
Background: Health knowledge, as an important resource of online health communities (OHCs), attracts users to engage in OHCs and improve the traffics within OHCs, thereby promoting the development of OHCs. Seeking and contributing health knowledge are basic activities in OHCs and are helpful for users to solve their health‐related problems, improve their health conditions and thus influence their evaluation of OHCs (ie perceived value of OHCs). However, how do patients’ health knowledge seeking and health knowledge contributing behaviours together with other factors influence their perceived value of OHCs? We still have little knowledge.Objective: In order to address the above gap, we root the current study in social cognitive theory and prior related literature on health knowledge sharing in OHCs and patients’ perceived value. We treat health knowledge seeking and health knowledge contributing behaviours as behavioural factors and structural social capital as an environmental factor and explore their impacts on patients’ perceived value of OHCs.Design: We have built a theoretical model composed of five hypotheses. We have designed a questionnaire composed of four key constructs and then collected data via an online survey.Setting and participants: We have distributed the questionnaire in two Chinese OHCs. We obtained a sample of 352 valid responses that were completed by patients having a variety of conditions.Results: The empirical results indicate that health knowledge seeking and health knowledge contributing have positive impacts on patients’ perceived value of OHCs. The impact of health knowledge seeking on patients’ perceived value of OHCs is greater than the impact of health knowledge contributing. In addition, structural social capital moderates the effects of health knowledge seeking and health knowledge contributing on patients’ perceived value of OHCs. It weakens the effect of health knowledge seeking but enhances the effect of health knowledge contributing on patients’ perceived value of OHCs.Conclusions: These findings contribute to the literature on patients’ perceived value of OHCs and on the role of structural social capital in OHCs. For OHC managers, they should provide their users more opportunities to seek or contribute health knowledge in their communities.
- 13 October 2020
- Published by Wiley in Health Expectations
- Vol. 23 (6) , 1614-1626
Open AccessSeeking or contributing? Evidence of knowledge sharing behaviours in promoting patients’ perceived value of online health communities
Background: Health knowledge, as an important resource of online health communities (OHCs), attracts users to engage in OHCs and improve the traffics within OHCs, thereby promoting the development of OHCs. Seeking and contributing health knowledge are basic activities in OHCs and are helpful for users to solve their health‐related problems, improve their health conditions and thus influence their evaluation of OHCs (ie perceived value of OHCs). However, how do patients’ health knowledge seeking and health knowledge contributing behaviours together with other factors influence their perceived value of OHCs? We still have little knowledge.Objective: In order to address the above gap, we root the current study in social cognitive theory and prior related literature on health knowledge sharing in OHCs and patients’ perceived value. We treat health knowledge seeking and health knowledge contributing behaviours as behavioural factors and structural social capital as an environmental factor and explore their impacts on patients’ perceived value of OHCs.Design: We have built a theoretical model composed of five hypotheses. We have designed a questionnaire composed of four key constructs and then collected data via an online survey.Setting and participants: We have distributed the questionnaire in two Chinese OHCs. We obtained a sample of 352 valid responses that were completed by patients having a variety of conditions.Results: The empirical results indicate that health knowledge seeking and health knowledge contributing have positive impacts on patients’ perceived value of OHCs. The impact of health knowledge seeking on patients’ perceived value of OHCs is greater than the impact of health knowledge contributing. In addition, structural social capital moderates the effects of health knowledge seeking and health knowledge contributing on patients’ perceived value of OHCs. It weakens the effect of health knowledge seeking but enhances the effect of health knowledge contributing on patients’ perceived value of OHCs.Conclusions: These findings contribute to the literature on patients’ perceived value of OHCs and on the role of structural social capital in OHCs. For OHC managers, they should provide their users more opportunities to seek or contribute health knowledge in their communities.